<?xml version="1.0" encoding="UTF-8"?>
<!-- generator="wordpress.com" -->
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
	xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd"
	xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
	xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"
	xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"
	>
<url><loc>https://newdrugapprovals.org/2026/04/14/bretisilocin/</loc><news:news><news:publication><news:name>New Drug Approvals</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-14T02:26:33+00:00</news:publication_date><news:title>Bretisilocin</news:title><news:keywords>Depression, health, mental-health, 5F-MET, bretisilocin, serotonin (5-HT2A) receptor agonist, 5-Fluoro-MET, 5-Fluoro-N-methyl-N-ethyltryptamine, 5-F-MET</news:keywords></news:news></url><url><loc>https://newdrugapprovals.org/2026/04/13/blixeprodil/</loc><news:news><news:publication><news:name>New Drug Approvals</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-04-13T02:31:48+00:00</news:publication_date><news:title>Blixeprodil</news:title><news:keywords>(R)-4-Fluorodeschloroketamine, (R)-4FDCK, GM1020, N-methyl-D-aspartate (NMDA) receptor antagonist, (R)-4-FDCK, GM-1020, blixeprodil</news:keywords></news:news></url></urlset>